Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Merck KGaA (MRK.DE) hired Danny Bar-Zohar as global head of development for its health care business. Previously, he was a partner at the Syncona venture capital firm and, before that, global head, clinical development & analytics at Novartis (NVS). Luciano Rossetti is retiring as global head of R&D.
About the Author Reprints
